Stress Reduction in Ovarian Cancer
The purpose of this study is to investigate the effects of a stress reduction program on the quality of life of ovarian cancer patients during primary adjuvant chemotherapy.
Ovarian, Fallopian, and Primary Peritoneal Cancer
BEHAVIORAL: Daily stress reduction program|OTHER: Attention control
Fatigue, Fatigue will be measured using the NIH PROMIS Cancer Fatigue survey instrument, 18 weeks (completion of chemotherapy)
Natural Killer Cell Activity, Cytotoxicity assays will be conducted to determine if the meditation-based intervention results in an increase in the ability of the NK cells to recognize and lyse cancer targets., 18 weeks (completion of chemotherapy)
The purpose of this study is to investigate the effects of a stress reduction program on the quality of life of ovarian cancer patients during primary adjuvant chemotherapy.